Clinical Trial Update: Naltrexone and Propranolol Combined With Immunotherapy [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial investigating the combination of naltrexone and propranolol with immunotherapy in patients with advanced melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Naltrexone (Naltrexone)
• Propranolol (propranolol)

Snippet

Sponsor: Sarah Weiss | Conditions: Advanced Melanoma | Phase 1 | Status: RECRUITING